Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunomodulation via paracrine signaling describes the regulation of immune responses through the secretion of soluble factors, primarily by mesenchymal stromal/stem cells (MSCs). These factors, including cytokines, chemokines, growth factors, and extracellular vesicles (EVs), influence the behavior of immune cells in the microenvironment, shifting the immune balance towards anti-inflammatory or tolerogenic states. It is not a single targetable protein, but a process involving multiple secreted factors and pathways.
Secretion of soluble factors (cytokines, chemokines, growth factors, EVs) that modulate immune cell activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunomodulation via Paracrine Signaling.